These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 20132195

  • 41. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
    Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF, Bladder Cancer Research Consortium.
    BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
    [Abstract] [Full Text] [Related]

  • 42. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
    Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF.
    BJU Int; 2013 Feb; 111(2):249-55. PubMed ID: 22727036
    [Abstract] [Full Text] [Related]

  • 43. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ, Hutterer GC, Shariat SF, Rogers CG, Palapattu GS, Lotan Y, Vazina A, Amiel GE, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Karakiewicz PI, Bladder Cancer Research Consortium.
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H.
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [Abstract] [Full Text] [Related]

  • 46. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB, Jones JS, Reuther AM, Dreicer R, Campbell SC, Sanii K, Klein EA.
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [Abstract] [Full Text] [Related]

  • 47. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
    Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M.
    Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
    [Abstract] [Full Text] [Related]

  • 48. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
    Ide H, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
    Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
    [Abstract] [Full Text] [Related]

  • 49. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
    Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE.
    J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
    [Abstract] [Full Text] [Related]

  • 50. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

  • 51. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, Thüroff JW.
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [Abstract] [Full Text] [Related]

  • 52. Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
    Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG.
    Cancer; 2003 Sep 01; 98(5):955-61. PubMed ID: 12942562
    [Abstract] [Full Text] [Related]

  • 53. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
    Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR.
    BJU Int; 2012 Sep 01; 110(6):804-11. PubMed ID: 22321341
    [Abstract] [Full Text] [Related]

  • 54. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J, Matsuyama H, Yamamoto Y, Hara T, Kawai Y, Sakano S, Ohmi C, Gondo T, Naito K.
    BJU Int; 2008 Aug 05; 102(5):572-5. PubMed ID: 18485032
    [Abstract] [Full Text] [Related]

  • 55. Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma.
    Umbreit EC, Crispen PL, Shimko MS, Farmer SA, Blute ML, Frank I.
    Cancer; 2010 Jul 15; 116(14):3399-407. PubMed ID: 20564121
    [Abstract] [Full Text] [Related]

  • 56. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL, Lin DW, Porter MP.
    Cancer; 2008 Jun 15; 112(11):2401-8. PubMed ID: 18383515
    [Abstract] [Full Text] [Related]

  • 57. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K.
    Int J Urol; 2009 Mar 15; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [Abstract] [Full Text] [Related]

  • 58. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
    Kikuchi E, Horiguchi Y, Nakashima J, Hatakeyama N, Matsumoto M, Nishiyama T, Murai M.
    J Urol; 2005 Dec 15; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
    [Abstract] [Full Text] [Related]

  • 59. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G, Papalia R, Ferriero M, Guaglianone S, Castelli E, Collura D, Muto G, Gallucci M.
    Int J Urol; 2013 Apr 15; 20(4):390-7. PubMed ID: 22970939
    [Abstract] [Full Text] [Related]

  • 60. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.
    Urology; 2010 Feb 15; 75(2):328-32. PubMed ID: 20018349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.